300298 三诺生物
已收盘 12-08 15:00:00
资讯
新帖
简况
三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%
证券之星 · 12-02
三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%
三诺生物为控股子公司心诺健康提供4300万元贷款担保
中金财经 · 12-02
三诺生物为控股子公司心诺健康提供4300万元贷款担保
三诺生物向控股子公司心诺健康提供6500万元财务资助
中金财经 · 11-30
三诺生物向控股子公司心诺健康提供6500万元财务资助
三诺生物：回购价格上限33.78元/股
证券之星 · 11-27
三诺生物：回购价格上限33.78元/股
三诺生物：已制定市值管理制度并实施股份回购
证券之星 · 11-14
三诺生物：已制定市值管理制度并实施股份回购
三诺生物（300298）披露第三期员工持股计划第一个锁定期届满提示性公告，11月13日股价上涨0.05%
证券之星 · 11-13
三诺生物（300298）披露第三期员工持股计划第一个锁定期届满提示性公告，11月13日股价上涨0.05%
三诺生物：将根据经营情况评估中期分红
证券之星 · 11-13
三诺生物：将根据经营情况评估中期分红
三诺生物：睿远基金持股变动为自主决策结果
证券之星 · 11-07
三诺生物：睿远基金持股变动为自主决策结果
股市必读：三诺生物（300298）今年截至11月6日累计跌幅已超30%
证券之星 · 11-07
股市必读：三诺生物（300298）今年截至11月6日累计跌幅已超30%
三诺生物(300298.SZ)累计回购1.22%股份 耗资1.39亿元
智通财经 · 11-03
三诺生物(300298.SZ)累计回购1.22%股份 耗资1.39亿元
三诺生物（300298）2025年三季报简析：增收不增利，公司应收账款体量较大
证券之星 · 10-25
三诺生物（300298）2025年三季报简析：增收不增利，公司应收账款体量较大
三诺生物新注册《三诺官方商城软件V1.0》项目的软件著作权
证券之星 · 10-24
三诺生物新注册《三诺官方商城软件V1.0》项目的软件著作权
三诺生物(300298.SZ)发布前三季度业绩，归母净利润2.11亿元，下降17.36%
智通财经 · 10-23
三诺生物(300298.SZ)发布前三季度业绩，归母净利润2.11亿元，下降17.36%
三诺生物新注册《医防融合慢病管理平台APP软件V1.0》等3个项目的软件著作权
证券之星 · 10-15
三诺生物新注册《医防融合慢病管理平台APP软件V1.0》等3个项目的软件著作权
三诺生物（300298）披露关于回购公司部分股份的进展公告，10月09日股价上涨0.15%
证券之星 · 10-09
三诺生物（300298）披露关于回购公司部分股份的进展公告，10月09日股价上涨0.15%
三诺生物：积极应对雅培欧洲专利诉讼
证券之星 · 09-25
三诺生物：积极应对雅培欧洲专利诉讼
三诺生物(300298.SZ)累计回购1.09%股份 耗资1.26亿元
智通财经 · 09-24
三诺生物(300298.SZ)累计回购1.09%股份 耗资1.26亿元
股市必读：三诺生物（300298）今年截至9月22日累计跌幅已超25%
证券之星 · 09-23
股市必读：三诺生物（300298）今年截至9月22日累计跌幅已超25%
股市必读：三诺生物（300298）9月17日董秘有最新回复
证券之星 · 09-18
股市必读：三诺生物（300298）9月17日董秘有最新回复
三诺生物：公司生产经营正常
证券之星 · 09-17
三诺生物：公司生产经营正常
加载更多
公司概况
公司名称：
三诺生物传感股份有限公司
所属行业：
专用设备制造业
上市日期：
2012-03-19
主营业务：
三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统。公司作为血糖监测领域领先企业，相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。
发行价格：
29.00
{"stockData":{"symbol":"300298","market":"SZ","secType":"STK","nameCN":"三诺生物","latestPrice":17.32,"timestamp":1765177413000,"preClose":17.34,"halted":0,"volume":4404119,"delay":0,"changeRate":-0.0012,"floatShares":451000000,"shares":560000000,"eps":0.5033,"marketStatus":"已收盘","change":-0.02,"latestTime":"12-08 15:00:00","open":17.34,"high":17.46,"low":17.3,"amount":76487100,"amplitude":0.0092,"askPrice":17.33,"askSize":130,"bidPrice":17.32,"bidSize":187,"shortable":0,"etf":0,"ttmEps":0.5033,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":5,"adr":0,"adjPreClose":17.34,"symbolType":"stock","openAndCloseTimeList":[[1765157400000,1765164600000],[1765170000000,1765177200000]],"highLimit":19.07,"lowLimit":15.61,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":560267306,"isCdr":false,"pbRate":3.04,"roa":"--","peRate":34.412875,"roe":"6.28%","epsLYR":0.589,"committee":-0.223667,"marketValue":9704000000,"turnoverRate":0.0098,"status":1,"floatMarketCap":7817000000},"requestUrl":"/m/hq/s/300298","defaultTab":"news","newsList":[{"id":"2588059968","title":"三诺生物（300298）披露关于回购公司部分股份的进展公告，12月02日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588059968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588059968?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:19","pubTimestamp":1764685146,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，三诺生物报收于17.75元，较前一交易日下跌0.73%，最新总市值为99.45亿元。该股当日开盘17.88元，最高17.88元，最低17.73元，成交额达5395.14万元，换手率为0.67%。近日，三诺生物传感股份有限公司发布关于回购公司部分股份的进展公告。公告显示，公司于2025年2月20日审议通过回购股份方案，拟使用自有资金及银行专项贷款，以集中竞价交易方式回购股份，用于员工持股计划、股权激励或转换可转债。回购符合既定方案及相关法律法规要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200039673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","300298","BK0114"],"gpt_icon":0},{"id":"2588037252","title":"三诺生物为控股子公司心诺健康提供4300万元贷款担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2588037252","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588037252?lang=zh_cn&edition=full","pubTime":"2025-12-02 19:39","pubTimestamp":1764675562,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司于近日发布公告，披露了为控股子公司长沙心诺健康产业投资有限公司提供担保的进展。作为风险控制措施，被担保人心诺健康已向三诺生物提供同等金额的反担保。公司表示，心诺健康经营稳定，资信状况良好，担保风险可控。截至目前，三诺生物及控股子公司的实际担保总余额占公司最近一期经审计净资产的4.30%，且不存在对合并报表外单位的担保及逾期担保情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251202/31839236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0114","BK0102","BK0251","300298"],"gpt_icon":0},{"id":"2587672867","title":"三诺生物向控股子公司心诺健康提供6500万元财务资助","url":"https://stock-news.laohu8.com/highlight/detail?id=2587672867","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587672867?lang=zh_cn&edition=full","pubTime":"2025-11-30 08:50","pubTimestamp":1764463814,"startTime":"0","endTime":"0","summary":"中访网数据 三诺生物传感股份有限公司发布公告，根据此前股东大会授权，公司于2025年11月28日与控股子公司长沙心诺健康产业投资有限公司签署《借款合同》，向其提供人民币6500万元的财务资助。本次操作后，公司对心诺健康的财务资助总余额达到4.6亿元，约占公司2024年末经审计净资产的13.70%。除此次资助外，公司无其他对外财务资助，亦无逾期未收回款项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251130/31833900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300298","BK0251","BK0114","BK0102"],"gpt_icon":0},{"id":"2586480240","title":"三诺生物：回购价格上限33.78元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586480240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586480240?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:48","pubTimestamp":1764247718,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物11月26日在投资者关系平台上答复投资者关心的问题。截至2025年10月31日，公司已累计回购公司股份6,827,500股，成交总金额为139,091,595.98元。根据2025年2月20日审议通过的回购方案，公司将在董事会审议通过后12个月内实施完成本次回购方案，回购价格上限不超过33.78元/股（含）。公司后续将结合市场情况在回购期限内适时推进本次回购计划，具体进展敬请关注公司后续公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0251","BK0114","BK0102"],"gpt_icon":0},{"id":"2583050345","title":"三诺生物：已制定市值管理制度并实施股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2583050345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583050345?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:48","pubTimestamp":1763124502,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物11月13日在投资者关系平台上答复投资者关心的问题。，麻烦董秘回答一下问题，不要老是当作看不到，谢谢三诺生物回复：您好！目前，公司生产经营正常，各项业务和研发项目稳健运行，且不存在任何应披露未披露事项。公司积极推动上市公司质量提升和市值管理工作，2025年4月，公司制定并审议通过《市值管理制度》；截至2025年10月31日，公司本轮已累计回购公司股份6,827,500股，成交总金额为139,091,595.98元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400038363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0251","BK0102"],"gpt_icon":0},{"id":"2583259972","title":"三诺生物（300298）披露第三期员工持股计划第一个锁定期届满提示性公告，11月13日股价上涨0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583259972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583259972?lang=zh_cn&edition=full","pubTime":"2025-11-13 22:44","pubTimestamp":1763045061,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，三诺生物报收于18.69元，较前一交易日上涨0.05%，最新总市值为104.71亿元。公司于近日发布公告称，三诺生物传感股份有限公司第三期员工持股计划第一个锁定期于2025年11月13日届满，可解锁股份375,000股，占公司当前总股本的0.07%。该员工持股计划股票来源于公司回购股份，已于2024年11月12日非交易过户至员工持股计划专用账户，过户数量为3,000,000股，占当时总股本的0.53%。锁定期分8期，每期解锁比例为12.50%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300042654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"gpt_icon":0},{"id":"2583508205","title":"三诺生物：将根据经营情况评估中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2583508205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583508205?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:12","pubTimestamp":1763025135,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物11月13日在投资者关系平台上答复投资者关心的问题。根据信息披露公平原则，公司将在定期报告中披露对应时点的股东信息。感谢您对公司中期分红策略的建议，后续公司将根据市场形势、经营情况及资金安排等多方面因素进行综合评估，如有相关计划，公司将按照规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300028971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0102","300298","BK0251"],"gpt_icon":0},{"id":"2581008196","title":"三诺生物：睿远基金持股变动为自主决策结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008196","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581008196?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:21","pubTimestamp":1762507274,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物(300298)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：睿远是与公司存在什么问题吗，为何清仓？三诺生物回复：您好！睿远基金旗下产品持有公司股份情况属于正常的市场投资行为，其持股变动为基金自主决策结果。公司尊重合规前提下每位股东的意愿。公司基本面稳健，生产经营正常有序。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700027552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0102","300298","BK0114"],"gpt_icon":0},{"id":"2581901328","title":"股市必读：三诺生物（300298）今年截至11月6日累计跌幅已超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581901328","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581901328?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:13","pubTimestamp":1762449195,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，三诺生物报收于18.55元，下跌0.43%，换手率1.8%，成交量8.14万手，成交额1.51亿元。交易信息汇总股价提醒11月6日三诺生物收盘报18.55元，跌0.43%，当日成交814.34万元。该股当年累计跌幅30.08%。近90天内共有15家机构对该股作出评级，其中买入评级12家，增持评级3家，机构目标均价为27.42元。资金流向11月6日主力资金净流出2028.27万元，游资资金净流入895.27万元，散户资金净流入1133.0万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700000899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2580026030","title":"三诺生物(300298.SZ)累计回购1.22%股份 耗资1.39亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580026030","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580026030?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:07","pubTimestamp":1762160856,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三诺生物(300298.SZ)公告，公司截至2025年10月31日以集中竞价交易方式累计回购公司股份682.75万股，占公司当前总股本的比例为1.22%，成交总金额为1.39亿元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三诺生物(300298.SZ)累计回购1.22%股份 耗资1.39亿元","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK0114","300298","BK0102"],"gpt_icon":0},{"id":"2578525428","title":"三诺生物（300298）2025年三季报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2578525428","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578525428?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:08","pubTimestamp":1761343730,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期三诺生物发布2025年三季报。截至本报告期末，公司营业总收入34.53亿元，同比上升8.52%，归母净利润2.11亿元，同比下降17.36%。本报告期三诺生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达166.92%。本次财报公布的各项数据指标表现一般。去年的净利率为7.78%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2577582052","title":"三诺生物新注册《三诺官方商城软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2577582052","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577582052?lang=zh_cn&edition=full","pubTime":"2025-10-24 01:38","pubTimestamp":1761241090,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三诺生物新注册了《三诺官方商城软件V1.0》项目的软件著作权。今年以来三诺生物新注册软件著作权23个，较去年同期增加了64.29%。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.45亿元，同比减15.28%。通过天眼查大数据分析，三诺生物传感股份有限公司共对外投资了12家企业，参与招投标项目718次；财产线索方面有商标信息843条，专利信息581条，著作权信息170条；此外企业还拥有行政许可1488个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400001401.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","300298","BK0102","BK0251"],"gpt_icon":0},{"id":"2577302313","title":"三诺生物(300298.SZ)发布前三季度业绩，归母净利润2.11亿元，下降17.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577302313","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577302313?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:49","pubTimestamp":1761223745,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三诺生物(300298.SZ)发布2025年三季度报告，该公司前三季度营业收入为34.53亿元，同比增长8.52%。归属于上市公司股东的净利润为2.11亿元，同比减少17.36%。归属于上市公司股东的扣除非经常性损益的净利润为1.8亿元，同比减少22.13%。基本每股收益为0.3827元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300298"],"gpt_icon":0},{"id":"2575245472","title":"三诺生物新注册《医防融合慢病管理平台APP软件V1.0》等3个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2575245472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575245472?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:48","pubTimestamp":1760464094,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三诺生物新注册了3个项目的软件著作权，包括《医防融合慢病管理平台APP软件V1.0》、《医防融合慢病管理平台V1.0》、《医防融合慢病管理小程序V1.0》等。今年以来三诺生物新注册软件著作权22个，较去年同期增加了57.14%。通过天眼查大数据分析，三诺生物传感股份有限公司共对外投资了12家企业，参与招投标项目718次；财产线索方面有商标信息843条，专利信息581条，著作权信息170条；此外企业还拥有行政许可1488个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500001227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"gpt_icon":0},{"id":"2574169387","title":"三诺生物（300298）披露关于回购公司部分股份的进展公告，10月09日股价上涨0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574169387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574169387?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:46","pubTimestamp":1760021178,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，三诺生物报收于19.96元，较前一交易日上涨0.15%，最新总市值为111.83亿元。近日，三诺生物传感股份有限公司发布关于回购公司部分股份的进展公告。公告显示，公司于2025年2月20日召开董事会及监事会会议，审议通过回购公司部分股份的方案，拟使用自有资金及银行回购专项贷款，以集中竞价交易方式回购股份，用于员工持股计划、股权激励或转换可转换公司债券。回购进展符合相关法律法规及公司回购方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0102","BK0251","BK0114"],"gpt_icon":0},{"id":"2570674250","title":"三诺生物：积极应对雅培欧洲专利诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2570674250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570674250?lang=zh_cn&edition=full","pubTime":"2025-09-25 17:06","pubTimestamp":1758791173,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物09月25日在投资者关系平台上答复投资者关心的问题。近期网传，雅培指控Menarini侵犯两项专利，并针对三诺生物和Menarini发起关于葡萄糖监测设备的临时禁令申请。雅培在UPC法庭对Menarini和三诺就EP3988471和EP4344633两项欧洲专利提起诉讼的情况属实，公司积极应对并对该诉讼提起了不侵权和雅培专利无效的抗辩。目前该案件仍在审理中，处于早期阶段且存在争议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500024665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0114","BK0102","BK0251"],"gpt_icon":0},{"id":"2569770861","title":"三诺生物(300298.SZ)累计回购1.09%股份 耗资1.26亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569770861","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569770861?lang=zh_cn&edition=full","pubTime":"2025-09-24 18:07","pubTimestamp":1758708467,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三诺生物(300298.SZ)公告，公司截至2025年9月24日以集中竞价交易方式累计回购公司股份612.75万股，占公司当前总股本的比例为1.09%，成交总金额为1.26亿元(不含交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0114","BK0251","300298","BK0102"],"gpt_icon":0},{"id":"2569734387","title":"股市必读：三诺生物（300298）今年截至9月22日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569734387","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569734387?lang=zh_cn&edition=full","pubTime":"2025-09-23 01:35","pubTimestamp":1758562515,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，三诺生物报收于20.08元，下跌0.59%，换手率1.51%，成交量6.8万手，成交额1.36亿元。当日关注点来自交易信息汇总：三诺生物股价连续4日下跌，当日收盘报20.08元，跌0.59%，年内累计跌幅达25.1%。来自交易信息汇总：该股获90天内13家机构评级，其中11家给予买入评级，机构目标均价为28.63元。前10个交易日内，主力资金合计净流出4507.43万元，期间股价累计下跌5.71%；融资余额累计增长3305.42万元，融券余量减少2.86万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300001293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0114","BK0251","300298"],"gpt_icon":0},{"id":"2568041142","title":"股市必读：三诺生物（300298）9月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2568041142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568041142?lang=zh_cn&edition=full","pubTime":"2025-09-18 03:51","pubTimestamp":1758138673,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，三诺生物报收于20.58元，下跌0.48%，换手率1.5%，成交量6.76万手，成交额1.39亿元。董秘最新回复投资者： 请问你们公司已经推出了第三代生物探针技术的CGM产品，竞争对手如雅培、硅基仿生有有推进类似的产品研发进展吗？目前雅培的CGM产品主要是基于第二代传感技术。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800002884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300298","BK0102","BK0114","BK0251"],"gpt_icon":0},{"id":"2568996974","title":"三诺生物：公司生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2568996974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568996974?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:49","pubTimestamp":1758113356,"startTime":"0","endTime":"0","summary":"证券之星消息，三诺生物09月17日在投资者关系平台上答复投资者关心的问题。公司目前生产经营正常，专注于糖尿病监测及管理领域，虽然目前市场上可能缺乏一个完全精准对应“糖尿病监测设备”单一细分领域的专属指数，但投资者可以参考更宽泛但相关性较高的指数来自主进行评估。在聚焦主业的同时，公司通过现金分红、股份回购及常态化投资者交流等措施增强市场信心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700038159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0251","BK0114","300298"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765177954332,"stockEarnings":[{"period":"1week","weight":-0.0247},{"period":"1month","weight":-0.0692},{"period":"3month","weight":-0.155},{"period":"6month","weight":-0.1636},{"period":"1year","weight":-0.3523},{"period":"ytd","weight":-0.3217}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"三诺生物传感股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"24597人(较上一季度增加58.52%)","perCapita":"18347股","listingDate":"2012-03-19","address":"湖南省长沙市岳麓区高新技术产业开发区谷苑路265号","registeredCapital":"56026万元","survey":" 三诺生物传感股份有限公司的主营业务是血糖监测系统的生产和销售。公司的主要产品是血糖监测系统。公司作为血糖监测领域领先企业，相继获得国内外权威机构的高度认可和荣誉。荣获“国家企业技术中心”、“国家工程研究中心”、“国家技术创新示范企业”、“国家知识产权优势企业”、“国家科技进步二等奖”和“国家绿色工厂”等资质。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三诺生物,300298,三诺生物股票,三诺生物股票老虎,三诺生物股票老虎国际,三诺生物行情,三诺生物股票行情,三诺生物股价,三诺生物股市,三诺生物股票价格,三诺生物股票交易,三诺生物股票购买,三诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三诺生物(300298)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三诺生物(300298)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}